Usefulness of serum biopterin as a predictive biomarker for childhood asthma control: A prospective cohort study.


Journal

Allergology international : official journal of the Japanese Society of Allergology
ISSN: 1440-1592
Titre abrégé: Allergol Int
Pays: England
ID NLM: 9616296

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 27 12 2017
revised: 14 06 2018
accepted: 01 08 2018
pubmed: 10 10 2018
medline: 2 4 2019
entrez: 10 10 2018
Statut: ppublish

Résumé

Pteridines are metabolites of tetrahydrobiopterin, which serves as co-enzyme of nitric oxide synthase. We sought to investigate the usefulness of pteridines as biomarkers for childhood asthma control. We conducted a single-center prospective cohort study involving 168 asthmatic children aged 4-17 years who visited the periodical asthma checkup program. Serum neopterin and biopterin levels were measured as pteridines at each visit along with measurement of FeNO, respiratory function tests, nasal eosinophil test, blood eosinophil count, and IgE level. We calculated coefficients for relation between pteridines and asthma control, which was assessed by questionnaires (JPAC: Japanese Pediatric Asthma Control Program). A total of 168 participants aged 10.3 ± 3.39 years (mean ± SD) with asthma were recruited. The participants in this study contained 58 patients (34.5%) of complete-controlled based on JPAC, 132 patients (76.0%) of well-controlled group based on GINA. FeNO and serum neopterin level did not correlate with following period's JPAC scores. In contrast, serum biopterin level significantly correlated with following period's JPAC total score (Coefficients 0.398; 95% CI 0.164 to 0.632; p value 0.001) and frequency of wheezing during exercise (Coefficients 0.272; 95% CI 0.217 to 0.328; p value < 0.001). We found serum biopterin effected the following period's control status of asthmatic children, thus monitoring biopterin level will be a useful for management of asthma to adjust treatment.

Sections du résumé

BACKGROUND BACKGROUND
Pteridines are metabolites of tetrahydrobiopterin, which serves as co-enzyme of nitric oxide synthase. We sought to investigate the usefulness of pteridines as biomarkers for childhood asthma control.
METHODS METHODS
We conducted a single-center prospective cohort study involving 168 asthmatic children aged 4-17 years who visited the periodical asthma checkup program. Serum neopterin and biopterin levels were measured as pteridines at each visit along with measurement of FeNO, respiratory function tests, nasal eosinophil test, blood eosinophil count, and IgE level. We calculated coefficients for relation between pteridines and asthma control, which was assessed by questionnaires (JPAC: Japanese Pediatric Asthma Control Program).
RESULTS RESULTS
A total of 168 participants aged 10.3 ± 3.39 years (mean ± SD) with asthma were recruited. The participants in this study contained 58 patients (34.5%) of complete-controlled based on JPAC, 132 patients (76.0%) of well-controlled group based on GINA. FeNO and serum neopterin level did not correlate with following period's JPAC scores. In contrast, serum biopterin level significantly correlated with following period's JPAC total score (Coefficients 0.398; 95% CI 0.164 to 0.632; p value 0.001) and frequency of wheezing during exercise (Coefficients 0.272; 95% CI 0.217 to 0.328; p value < 0.001).
CONCLUSIONS CONCLUSIONS
We found serum biopterin effected the following period's control status of asthmatic children, thus monitoring biopterin level will be a useful for management of asthma to adjust treatment.

Identifiants

pubmed: 30297096
pii: S1323-8930(18)30120-5
doi: 10.1016/j.alit.2018.08.012
pii:
doi:

Substances chimiques

Biomarkers 0
Biopterins 0
Nitric Oxide 31C4KY9ESH

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

96-100

Informations de copyright

Copyright © 2018 Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.

Auteurs

Saki Kasuga (S)

Department of Pediatrics, Osaka City University Graduate School of Medicine, Osaka, Japan. Electronic address: m2071993@med.osaka-cu.ac.jp.

Daijiro Kabata (D)

Department of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka, Japan.

Tomoko Sakaguchi (T)

Department of Pediatrics, Osaka City University Graduate School of Medicine, Osaka, Japan.

Satoshi Kudoh (S)

Department of Pediatrics, Osaka City University Graduate School of Medicine, Osaka, Japan.

Satsuki Nishigaki (S)

Department of Pediatrics, Osaka City University Graduate School of Medicine, Osaka, Japan.

Yusuke Higa (Y)

Department of Pediatrics, Osaka City University Graduate School of Medicine, Osaka, Japan.

Shiori Fujikawa (S)

Department of Pediatrics, Osaka City University Graduate School of Medicine, Osaka, Japan.

Hiroko Fujitani (H)

Department of Pediatrics, Osaka City University Graduate School of Medicine, Osaka, Japan.

Ayumi Shintani (A)

Department of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka, Japan.

Takashi Hamazaki (T)

Department of Pediatrics, Osaka City University Graduate School of Medicine, Osaka, Japan.

Haruo Shintaku (H)

Department of Pediatrics, Osaka City University Graduate School of Medicine, Osaka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH